[外语类试卷]大学英语六级模拟试卷116及答案与解析.doc
《[外语类试卷]大学英语六级模拟试卷116及答案与解析.doc》由会员分享,可在线阅读,更多相关《[外语类试卷]大学英语六级模拟试卷116及答案与解析.doc(51页珍藏版)》请在麦多课文档分享上搜索。
1、大学英语六级模拟试卷 116及答案与解析 一、 Part I Writing (30 minutes) 1 1. 目前很多父母在子女高中毕业前就送他们出国学习 2形成这种趋势的原因 3我对此的看法 二、 Part II Reading Comprehension (Skimming and Scanning) (15 minutes) Directions: In this part, you will have 15 minutes to go over the passage quickly and answer the questions attached to the passage.
2、 For questions 1-4, mark: Y (for YES) if the statement agrees with the information given in the passage; N (for NO) if the statement contradicts the information given in the passage; NG (for NOT GIVEN) if the information is not given in the passage. 2 A Dose of Reality Major Reality Check When the p
3、ain reliever Vioxx was withdrawn from the market last fall after the announcement that it increased patients risk of heart attacks and strokes, millions of Americans panicked. The sometimes sensationalized headlines didnt help. People wondered, “Should I trust my doctor?“ “Could a medication that I
4、thought would help me actually kill me?“ “Is our drug safety system broken?“ Suddenly, ads for the drug were replaced with ads looking for Vioxx “victims“. Law firms across the nation began recruiting anyone who had ever taken the drug as plaintiffs (原告 ) for class-action (公诉 ) suits. Merck, the com
5、pany that developed the drug, could be liable for billions of dollars, making it one of the costliest liability cases ever. No surprise, then, that Mercks stock plummeted(垂直落下 ) 40 percent in just six weeks. But the real cost was even greater. Not only did patients stop taking Vioxx but, doctors say
6、, many people stopped taking their other medicines, too-sometimes putting their health at serious risk. Vioxx was the first pebble in the pharmaceutical rock slide. Soon, accusations about a spate of other drugs were making headlines, including all COX-2 inhibitors which, like Vioxx, relieve pain. T
7、he charges didnt stop there. The FDA was accused of simply rubber-stamping new drugs; drug companies were blamed for hiding information about unsafe products; and the efficacy(功效 ) of clinical trials that did not reveal how large numbers of people would react was questioned. But one question that wa
8、s rarely asked could determine whether or not pharmaceutical companies continue to develop and produce breakthrough medications that can save or extend lives and help people live without pain. The question: do Americans expect drugs to be risk-free? And, if someone suffers a bad reaction, will lawye
9、rs rather than doctors be the first people we call? Panic over Pills: Overreaction? During the tan-year period between 1994 and 2004, the FDA approved 321 completely new drugs (this doesnt include approvals for changes to existing medicines ), bringing the total to more than 10,000 drug products on
10、the market. During that same period, eight drugs were withdrawn for reasons of safety, such as the diet drug fenfluramine (fen-phen, associated with heart-valve disease) and the allergy drug Seldane (linked to heart arrhythmias). But the Vioxx recall created a shock wave for the American consumer li
11、ke no other. Many people had come to depend on their “meals“, and they expected them to be safe, too, especially when they cost so much. Prescription drugs account for, some say, the fastest growing segment (about one-tenth) of all health expenditures, with some specialty drugs costing hundreds of d
12、ollars per dose. “With Vioxx, the real shock and outrage came when there was a suggestion that people in authority may have known about these harmful side effects and not shared them with doctors or the public,“ says Anne Woodbury, chief health advocate for the Center for Health Transformation, a th
13、ink tank founded by Newt Gingrich. It made people question their faith in the pharmaceutical industry, federal regulators and physicians-those we trust to make sure our drugs are safe. Before, taking a newly prescribed pill with a slug of water was as routine as brushing your teeth. For many people,
14、 this is no longer the case. People have reason to worry. In clinical trial data submitted to-the FDA, Vioxx showed no connection to heart problems. The drug was approved in May 1999. But after Vioxx hit the market and grew in popularity, heart problems were revealed- lots of them. Tens of thousands
15、 of people may have been affected, and Merck was accused of hiding that information. “The system is not perfect,“ comments Marianne J. Legato, MD, professor of clinical medicine at Columbia University College of Physicians and Surgeons in New York City. “Sometimes a company may not want to show data
16、 that are negative till they really know whats going on. But its ridiculous to suggest that they would suppress things willy-nilly, because if a drug is going to cause severe side effects, its not in their best interest to hide that.“ How Side Effects Emerge How can dangerous side effects take years
17、, or even decades, to become known? A new drug is first tested on animals. If the results indicate that its likely to be both safe and effective, the company applies to the FDA for permission to begin testing it in humans. Human studies have three phases: to evaluate safety, to determine effectivene
18、ss, and to verify safety, dosage and effectiveness. Although a trial may extend as long as five years mad often includes between 3,000 and 10,000 people, each participant may only receive the medication for a period of weeks or months. Statistically, rare and dangerous side effects may not emerge un
19、til millions of people have used the drug, after FDA approval. So why dont we test drugs on more people and for longer periods of time? For one thing, quicker approvals may save lives, as with drugs for AIDS or a vaccine for a newly emerging flu pandemic. Another reason is cost. “It already costs a
20、billion dollars to get a drug from an idea to the market,“ says Corr. “If we had to study a million patients before we took a drug to market, there would never be another drug.“ Monitoring after Approval After a drug is approved, it is subject to post-market surveillance(监督 ). The FDA analyzes repor
21、ts of “adverse events“, or drug side effects, which come from the industry, from ongoing clinical trials and through its Med Watch program, to which consumers, physicians, pharmacists and other health professionals voluntarily report problems. Negative reports about a drug thats on the market can yi
22、eld crucial new information. “Clinical trials that are negative are, many times, just as important as the trials that show positive results,“ says Marvin Lipman, MD, chief medical adviser for Consumer Reports. Legislation was introduced in both the House and Senate in October 2004 to establish a reg
23、istry of all clinical trials and their results. “We are the most regulated industry in the world,“ says Corr. “And frankly, thats how it should be. If there is a problem with a drug, we want to know about it sooner rather than later.“ Consumers may know sooner too. In February the FDA announced the
24、creation of an independent Drug Safety Oversight Board to provide expanded and faster drug-safety information to doctors and patients. While there will always be risks, the public may be better equipped to judge and act on them. “We still need to be willing to take personal responsibility for assess
- 1.请仔细阅读文档,确保文档完整性,对于不预览、不比对内容而直接下载带来的问题本站不予受理。
- 2.下载的文档,不会出现我们的网址水印。
- 3、该文档所得收入(下载+内容+预览)归上传者、原创作者;如果您是本文档原作者,请点此认领!既往收益都归您。
下载文档到电脑,查找使用更方便
2000 积分 0人已下载
下载 | 加入VIP,交流精品资源 |
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 外语类 试卷 大学 英语六级 模拟 116 答案 解析 DOC
